Patients’ characteristics | Total (n = 121) | <500 cells/μl (n = 7) | ≥500 cells/μl (n = 114) | p-value | <350 cells/μl (n = 3) | ≥350 cells/μl (n = 118) | p-value |
Age <10 ≥10 |
88 33 |
5 (5.68%) 2 (6.06%) |
83 (94.32%) 31 (93.94%) |
1.0 |
3 (3.44%) 0 (0%) |
85 (96.56%) 33 (100%) |
0.56 |
Sex Male female | 70 51 | 4 (5.71%) 3 (5.88%) | 66 (94.29%) 48 (94.12%) |
1.0 | 2 (2.86%) 1 (2%) | 68 (97.14%) 50 (98%) |
1.0 |
TLC <50,000 cells/μl ≥50,000 cells/μl | 83 38 | 3 (3.62%) 4 (10.53%) | 80 (96.38%) 34 (89.47%) |
0.20 | 2 (2.41%) 1 (2.63%) | 81 (97.59%) 37 (97.37%) |
1.0 |
Mediastinal mass (119)* Present absent |
15 104 |
1 (6.67%) 6 (5.77%) |
14 (93.33%) 98 (94.23%) |
1.0 |
0 3 (2.88%) |
15 (100%) 101 (97.12%) |
1.0 |
Immunophenotyping B-ALL T-ALL |
95 26 |
5 (5.26%) 2 (7.69%) |
90 (94.74%) 24 (92.31%) |
0.64 |
2 (2.11%) 1 (3.85%) |
93 (97.89%) 25 (96.15%) |
0.52 |
CNS involvement Yes no |
7 114 |
0 7 (6.14%) |
7 (100%) 107 (93.86%) |
1.0 |
0 3 (2.63%) |
7 (100%) 111 (97.37%) |
1.0 |
Early response RER SER |
106 15 |
7 (6.60%) 0 |
99 (93.40%) 15 (100%) |
0.60 |
3 (2.83%) 0 |
103 (97.17%) 15 (100%) |
1.0 |
Induction response CR not |
104 17 |
7 (6.73%) 0 |
97 (93.27%) 17 (100%) |
0.59 |
3 (2.88%) 0 |
101 (97.12%) 17 (100%) |
1.0 |